Northwestern Mutual, a financial services company providing comprehensive financial planning through insurance and investments, has announced that Teresa Bitetti and Andrew Feldstein have been appointed to serve on its board of trustees.
As a mutual company with a responsibility to its policyowners, Northwestern Mutual has a board of trustees elected by its policyowners with responsibility for oversight and governance on company matters.
Bitetti currently serves as president of Takeda's Global Oncology Business Unit, where she leads all aspects of the company's oncology business, with major markets in the United States, Europe and Japan. She has extensive experience driving product growth in both emerging and mature markets, with a focus on launching new treatments and a proven track record in product development and commercialization. Bitetti also serves on the board of directors for Aura Biosciences and Osmol Therapeutics. She holds a bachelor's degree from Wellesley
